Clinical Chemistry, Malmö
351 – 360 of 1324
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2014
-
Mark
Targeting exosites of activated protein C as therapeutic possibility?
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
A high frequency of MDSCs in sepsis patients, with the granulocytic subtype dominating in gram-positive cases.
(
- Contribution to journal › Article
-
Mark
Protein S and factor V in regulation of coagulation on platelet microparticles by activated protein C.
(
- Contribution to journal › Article
-
Mark
Targeted Prostate Cancer Screening in BRCA1 and BRCA2 Mutation Carriers: Results from the Initial Screening Round of the IMPACT Study.
2014) In European Urology(
- Contribution to journal › Article
-
Mark
Influence of blood prostate specific antigen levels at age 60 on benefits and harms of prostate cancer screening : Population based cohort study
(
- Contribution to journal › Article
-
Mark
A pharmacodynamic comparison of 5 anti-platelet protocols in patients with ST-elevation myocardial infarction undergoing primary PCI.
(
- Contribution to journal › Article
-
Mark
Proteolytic Activity of Prostate-Specific Antigen (PSA) towards Protein Substrates and Effect of Peptides Stimulating PSA Activity.
(
- Contribution to journal › Article
-
Mark
Clinically relevant non-neutralizing anti-FVIII antibodies in a hemophiliac
(
- Contribution to journal › Letter
-
Mark
High frequency of myeloid-derived suppressor cells in sepsis patients, with the granulocytic subtype dominating in Gram-positive cases
(
- Contribution to journal › Published meeting abstract
-
Mark
Assay discrepancy in mild haemophilia A
(
- Contribution to journal › Scientific review